ArticleFrontiers in public health2024

Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant.

Sophie Marbaix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.